Read More Pharma Industry News SciSparc targets quantum-powered bio data analysis with NeuroThera majority acquisition move Find out how SciSparc is moving into quantum-powered bio data analysis through NeuroThera’s majority acquisition plan and what it could mean for investors. bySoujanya RaviDecember 2, 2025